← Back to Search

Intervention Arm for Sickle Cell Disease

N/A
Waitlist Available
Led By Melissa Faith
Research Sponsored by Johns Hopkins All Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, post intervention (weeks 4-8 after study enrollment), and 16-20 weeks after study enrollment
Awards & highlights

Study Summary

Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Sickle Cell Disease

Eligible Conditions
  • Sickle Cell Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, post intervention (weeks 4-8 after study enrollment), and 16-20 weeks after study enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, post intervention (weeks 4-8 after study enrollment), and 16-20 weeks after study enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in sickle cell disease medication adherence
Intervention acceptability as assessed by the Abbreviated Acceptability Rating Profile
Intervention feasibility as assessed by the fidelity rating
Secondary outcome measures
Change in anxiety as assessed by the PROMIS Anxiety Symptoms- Short Form or PROMIS Adult Anxiety Symptoms Short Form
Mental Depression
Change in health literacy as assessed by the Health Literacy Skills Instrument- Short Form for adults or the Health Literacy Assessment Scale for Adolescents (HAS-A)
+4 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment1 Intervention
Intervention sessions will occur ~once per week, with all 4 sessions being completed within 4-8 weeks. Each session will include an education and motivational interviewing (MI) component.
Group II: Education only ArmActive Control1 Intervention
Participants in the education-only control arm will receive one education session. The education session will occur via telephone or telehealth. Education will include medication purpose and adherence strategy recommendations delivered in a single telehealth session.

Find a Location

Who is running the clinical trial?

Johns Hopkins All Children's HospitalLead Sponsor
43 Previous Clinical Trials
5,007,518 Total Patients Enrolled
Melissa FaithPrincipal InvestigatorJohns Hopkins All Children's Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Sickle Cell Disease
2021. "Pilot Evaluation of a Motivational Interviewing Intervention Targeting Adherence Behaviors in Youth With Sickle Cell Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04877054.
All > Sickle Cell Disease > Sickle Cell
~6 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top